5/20/2024China Set to Ease Controls on Genetic Resources to Plug Biotech Innova...

5/20/2024AZ to Build US$1.5B Cancer Drug Plant In Singapore, Reduce Industry's ...

5/17/2024Pharma Facing Growing Risks From Geopolitics, Industry Leaders Warn (S...

5/16/2024A Snapshot of Key Events in China This Week (AmCham China Newsletter /...

5/15/2024China Biopharma Tracker – April 2024 (PharmaDJ)

5/15/2024Chinese Biotech Crackdown Would Reset U.S. Drug Development (Axios)

5/15/2024China Biotech Podcast: BIOSECURE Markup, Biotech Pipeline Updates (Scr...

5/10/2024House's Updated Biosecurity Bill Sets 2032 Decoupling Deadline for Ind...

5/9/2024Chinese Drug Makers Trim, Boost Pipelines In New R&D Drive (Scrip Cite...

5/7/2024China's Share of Global API Imports Surges Post-pandemic (The pharmale...

5/7/2024Can EU Wean Itself Off Essential Drugs from China, India? (DW)

5/1/2024Biotech Giants, Lawyers Warn of 'Dramatic Impact' (Asian Legal Busines...

4/29/2024Key Considerations for Entering China's Healthcare Market

4/29/2024A US-China Pharma Drug War in the Making (Asia Times)

4/29/2024WuXi Wants to Regain Client Confidence Amid Claims of IP Transfer to C...

4/25/2024Roche Unruffled by China Bill as It Looks to Grow Roots in the Region ...

4/23/2024Free Pricing in China for Highly Innovative Medicines (LinkedIn)

4/19/2024How BIO CEO's Cozy Relationship with WuXi Soured (STAT)

4/19/2024China's Drugmakers Can't Sell mRNA Shots But Haven't Quit Yet (Reuters...

4/17/2024A Risky Bet: Zai Lab's Uncertain Future (Seeking Alpha)

4/16/2024America Hits Chinese Biotech — And Its Own Drugmakers (Economist)

4/15/2024The Pharmaceutical Playbook for Asia’s Private Market (PharmExec)

4/15/2024China Biopharma Tracker – Q1 2024 (PharmaDJ)

4/11/2024Geopolitics Threatens Chinese Biotechs' Hot Out-licensing Biz (Fierce ...

4/11/2024Drugmakers Race to Find Alternative Suppliers as US Cracks Down on Chi...

4/10/2024Biosimilars Coming into Their Own in China, Despite Concerns (Bioworld...

4/9/2024CEO Podcast: Hengrui's US Subsidiary's CEO, CMO On Chinese Pharma Goin...

4/5/2024Foreign Investors Fled Chinese Biotech After the Pandemic. They Still ...

4/3/2024Chinese ADC Investment Boom in Question With China-U.S. R&D Relations ...

4/3/2024What To Know About Jiyoutai - China's First Potential Ozempic Challeng...

Page:2/7 Total number of articles:181: [First][<<] [1] [2] [3] [4] [5] [>>] [End]